U.S. private equity firm Hellman & Friedman is exploring a sale of medical devices maker Cordis, aiming for a valuation exceeding $9 billion. Several publicly traded medical device companies are reportedly considering bids. Hellman & Friedman acquired Cordis in 2021 for approximately $1 billion.

H&F weighs $9 billion-plus sale of medical device maker Cordis: Report

Take control of your investments and grow your wealth with access to exclusive stock ideas, sectoral trends, and expert analysis.

Get access to Stock Score, a comprehensive analysis of a company's fundamentals, solvency, growth, risk, and ownership.
Evaluate the upside potential of a stock and make informed investment decisions.
Buy low and sell high with our expert guidance.

Discover where market bulls are investing and identify the right stocks for your portfolio.
Analyze market sentiments and identify trend reversals for strategic decisions.
Get expert advice from ET appointed, SEBI registered financial experts.

ePaper - Print View: Read the PDF version of ET newspaper and download it for offline access.
ePaper - Digital View: Get your daily newspaper delivered to your inbox every day.
Wealth Edition: Manage your money efficiently with our weekly money management guide.